ACE2 and COVID-19: In another study, Godfrey et al. have developed a GNP-based LFA to determine protected populations against COVID-19 by detection of RBD-ACE-2 neutralizing antibodies, consisting of more than 90% of COVID-19 neutralizing antibodies [55].